Proposed new colonoscopy items will fail 10% of patients: AMA
The MBS Review Taskforce wants to limit surveillance colonoscopies

Proposed Medicare items for surveillance colonoscopies are too strict and could lead to the suboptimal treatment of 10% of patients, the AMA has warned.
The MBS Review Taskforce has recommended a new set of five items — all worth $334.35 — that would restrict funding for screening colonoscopies when not based on a positive FOBT result.